iBio, Inc. (IBIO) stock
Close on Nov 13, 2026Market cap $47.05MP/E –Yield –
iBio statistics
77 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 9, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.62
- 2.22
Enterprise valuationIndustry
- EV / Sales
- -27.54
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 497.1%
- 10.8%
- Shares Change (QoQ)
- 15.5%
- 0.50%
- Float
- 64M
- 49M
- Shares Held by Insiders
- 0.47%
- 11.7%
- Shares Held by Institutions
- 54.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 8.05%
- -0.80%
- Short % of Float
- 6.30%
- 9.01%
- Short % of Shares Outstanding
- 6.27%
- 6.30%
- Days to Cover
- 7.15
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $3.82
- –
- 52-Week Low
- $0.69
- –
- 20-Day Moving Average
- $0.78
- –
- 50-Day Moving Average
- $0.98
- –
- 200-Day Moving Average
- $1.62
- –
- Average True Range (14)
- $0.07
- –
- Price Change (1 Week)
- -0.93%
- -1.15%
- Price Change (1 Month)
- -6.53%
- -4.87%
- Price Change (3 Months)
- -49.5%
- -21.0%
- Price Change (6 Months)
- -50.2%
- -20.6%
- Price Change (YTD)
- -62.1%
- -23.6%
- Price Change (1 Year)
- -41.5%
- -22.4%
- Price Change (3 Years)
- -86.9%
- -29.5%
- Price Change (5 Years)
- -99.8%
- -77.9%
- Price Change (10 Years)
- -100.0%
- -65.4%
- Average Volume (10 Days)
- 400,010
- –
- Average Volume (20 Days)
- 506,590
- –
- Average Volume (90 Days)
- 692,592
- –
- Relative Volume
- 0.66
- 0.70
- Relative Strength Index (14)
- 38.8
- 43.4
- Volatility (1 Year)
- 104.6%
- 80.1%
- Beta (5 Years)
- 1.12
- 1.07
MarginsIndustry
- EBITDA Margin
- -3491.0%
- -27.7%
- FCF Margin
- -2566.3%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -51.8%
- -49.9%
- Return on Assets (ROA)
- -45.6%
- -40.6%
- Return on Invested Capital (ROIC)
- -728.0%
- -32.9%
- Return on Capital Employed (ROCE)
- -46.9%
- -37.9%
Financial positionIndustry
- Current Ratio
- 9.48
- 3.30
- Quick Ratio
- 8.95
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- 115.0%
- 6.82%
- Revenue Growth (5Y CAGR)
- -46.9%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.01
- 0.40
- Revenue Per Employee
- $46.74K
- $429.29K
- Profits Per Employee
- -$1.52M
- -$689.41K
- Employee Count
- 23
- 74
- WACC
- 10.7%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $76.65M
- $17.76M
- Net Cash Per Share
- $1.19
- $0.80
- Equity (Book Value)
- $78.57M
- $53.89M
- Book Value Per Share
- $1.22
- $1.50
- Tangible Book Value
- $76.00M
- $27.13M
- Working Capital
- $72.67M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$648.00K
- -$1.00M
- FCF Per Share
- -$0.43
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -74.1%
- -21.8%
- FCF Yield
- -58.6%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $0
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -3.49
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | IBIO | S&P 500 | Difference | IBIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -6.4% | -3.0% | −3.4 pts | ||
| 3 months | -47.7% | -2.8% | −45.0 pts | ||
| Year to date | -62.1% | +11.5% | −73.6 pts | ||
| 1 year | -36.4% | +13.5% | −49.8 pts | ||
| 3 years | -87.4% | +77.7% | −165.1 pts | -49.8% | +21.1% |
| 5 years | -99.8% | +72.6% | −172.4 pts | -71.4% | +11.5% |
| 10 years | -100.0% | +308.2% | −408.1 pts | -55.3% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M IBIO shares were sold short on Oct 30, 2026, up 8.0% from the previous report, or 6.30% of the shares available to trade. At recent volumes it would take 7.2 days to buy them back. Over the last 20 sessions, 44.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 4,033,302 | +8.0% | 563,738 | 7.2 |
| Oct 15, 2026 | 3,732,883 | -11.2% | 1,064,661 | 3.5 |
| Sep 30, 2026 | 4,202,419 | -14.9% | 681,565 | 6.2 |
| Sep 15, 2026 | 4,936,917 | -5.1% | 494,351 | 10.0 |
| Aug 31, 2026 | 5,204,475 | +3.5% | 895,038 | 5.8 |
| Aug 14, 2026 | 5,027,874 | -1.5% | 452,026 | 11.1 |
| Jul 31, 2026 | 5,105,713 | -5.2% | 732,757 | 7.0 |
| Jul 15, 2026 | 5,384,479 | +14.7% | 1,336,493 | 4.0 |
| Jun 30, 2026 | 4,694,085 | +25.0% | 924,957 | 5.1 |
| Jun 15, 2026 | 3,755,035 | -0.1% | 780,149 | 4.8 |
| May 29, 2026 | 3,760,082 | +10.3% | 781,885 | 4.8 |
| May 15, 2026 | 3,408,695 | -0.2% | 958,081 | 3.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?